Trials / Conditions / Atypical Endometrial Hyperplasia

Atypical Endometrial Hyperplasia

24 registered clinical trials studyying Atypical Endometrial Hyperplasia — 10 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	SHAPE-ENDO: Multimodal Pre-Surgical Optimization in Patients With Obesity and Early-Stage Endometrial Cancer NCT07462663	Hospital Universitari de Bellvitge	—
Recruiting	Intrauterine Injection of Type III Collage in FST of EC/AEH NCT07377734	Wang Jianliu	Phase 2
Not Yet Recruiting	Ultrasound and Histology in AEH and Early EEC Treated Conservatively NCT07028242	Fondazione Policlinico Universitario Agostino Gemelli IRCCS	—
Recruiting	Medroxyprogesterone Acetate Plus Atorvastatin in Young Women With Early Endometrial Carcinoma and Atypical End NCT05675787	Peking University People's Hospital	Phase 2
Active Not Recruiting	GnRHa + Letrozole in Obese Progestin-insensitive Endometrial Atypical Hyperplasia Patients NCT06390904	Xiaojun Chen	Phase 2 / Phase 3
Recruiting	GnRHa + Letrozole in Non-obese Progestin-insensitive Endometrial Cancer and Atypical Hyperplasia Patients NCT05316935	Xiaojun Chen	Phase 2 / Phase 3
Recruiting	GnRHa + Letrozole in Obese Progestin-insensitive Endometrial Cancer Patients NCT06379113	Xiaojun Chen	Phase 2 / Phase 3
Recruiting	Weight Management Plus LNG-IUS/Megestrol Acetate in Endometrial Atypical Hyperplasia NCT05316493	Xiaojun Chen	Phase 2 / Phase 3
Completed	Loxenatide Plus LNG-IUS in Endometrial Atypical Hyperplasia NCT05172999	Fudan University	Phase 2 / Phase 3
Recruiting	Patient-derived Tumor-like Cell Clusters Predict Progesterone Sensitivity in Patients With Early Endometrial C NCT05647109	Peking University People's Hospital	—
Recruiting	Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical NCT05051722	Mayo Clinic	—
Withdrawn	Liraglutide Plus Megestrol Acetate in Endometrial Atypical Hyperplasia NCT04683237	Xiaojun Chen	Phase 2 / Phase 3
Terminated	Metformin Plus Megestrol Acetate As a Fertility-sparing Treatment in Patients with Atypical Endometrial Hyperp NCT04607252	Fudan University	Phase 2 / Phase 3
Completed	Megestrol Acetate Plus Rosuvastatin in Young Women With Atypical Endometrial Hyperplasia NCT04491682	Fudan University	Phase 2 / Phase 3
Completed	LVN- IUS Versus Oral Megesterol Acetate in Treatment of Atypical Endometrial Hyperplasia NCT04385667	Zagazig University	Phase 2 / Phase 3
Active Not Recruiting	Megestrol Acetate With or Without Pterostilbene in Treating Patients With Endometrial Cancer Undergoing Hyster NCT03671811	City of Hope Medical Center	Phase 2
Recruiting	Value of LNG-IUS as Fertility-preserving Treatment of EAH and EC NCT03463252	West China Second University Hospital	Phase 2 / Phase 3
Completed	Megestrol Acetate Plus LNG-IUS in Young Women With Endometrial Atypical Hyperplasia NCT03241888	Fudan University	Phase 2 / Phase 3
Active Not Recruiting	Levonorgestrel-Releasing Intrauterine System With or Without Everolimus in Treating Patients With Atypical Hyp NCT02397083	M.D. Anderson Cancer Center	Phase 2
Withdrawn	Megestrol Acetate or Levonorgestrel-Releasing Intrauterine System in Treating Patients With Atypical Endometri NCT01943058	University of Southern California	Phase 2
Active Not Recruiting	CA-IX, p16, Proliferative Markers, and HPV in Diagnosing Cervical Lesions in Patients With Abnormal Cervical C NCT00892866	GOG Foundation	N/A
Active Not Recruiting	Levonorgestrel-Releasing Intrauterine System in Treating Patients With Complex Atypical Hyperplasia or Grade I NCT00788671	M.D. Anderson Cancer Center	Phase 2
Completed	Management of Atypical Endometrial Hyperplasia and Endometrial Carcinoma Using Megestrol Acetate NCT00483327	NYU Langone Health	Phase 2
Completed	Resectoscopic Treatment of Atypical Endometrial Polyps in Fertile Women NCT00490087	IRCCS Burlo Garofolo	Phase 3